Business

CTLLAB Exempt from RPT Disclosure for FY26

April 22, 2026 1,390 views 1 min read
CTLLAB Exempt from RPT Disclosure for FY26

CTLLAB Exempt from RPT Disclosure for FY26


Clinitech Laboratory Ltd (CTLLAB) has filed an undertaking confirming the non-applicability of disclosure requirements under Regulation 23 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, concerning Related Party Transactions (RPT). This exemption is valid for the half-year and financial year ending March 31, 2026. The company qualifies for this exemption under Regulation 15 of SEBI (LODR) Regulations, 2015, as it is listed on the SME portal of BSE Limited and does not exceed the specified threshold limits for RPT disclosures.